共 27 条
[1]
Sjödahl G(2012)A molecular taxonomy for urothelial carcinoma Clin Cancer Res 18 3377-3386
[2]
Yafi FA(2011)First-and second-line therapy for metastatic urothelial carcinoma of the bladder Curr Oncol 18 695-249
[3]
North S(2021)Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 71 209-1221
[4]
Kassouf W(2013)Urothelial carcinoma of the bladder and the upper tract: disparate twins J Urol 189 1214-79
[5]
Sung H(2021)European Association of Urology guidelines on upper urinary tract urothelial carcinoma: 2020 update Eur Urol 79 62-1026
[6]
Green DA(2019)18F-FDG PET/CT and urothelial carcinoma: impact on management and prognosis—a multicenter retrospective study Cancers 11 700-74
[7]
Rouprêt M(2017)Pembrolizumab as second-line therapy for advanced urothelial carcinoma N Engl J Med 376 1015-732
[8]
Zattoni F(2018)Low levels of PSMA expression limit the utility of 18 F-DCFPyL PET/CT for imaging urothelial carcinoma Ann Nucl Med 32 69-3214
[9]
Bellmunt J(2020)Assessing the feasibility and accuracy of high-resolution microultrasound imaging for bladder cancer detection and staging Eur Urol 77 727-1237
[10]
Campbell SP(2015)Diagnostic value of [18 F] FDG-PET and PET/CT in urinary bladder cancer: a meta-analysis Tumor Biology 36 3209-e395